H eart failure (HF) is a common condition with an unfavorable prognosis and a severely impaired quality of life. Despite significant improvement in the management of cardiovascular disorders, the age-adjusted incidence of HF has not declined substantially during the past few decades. 1, 2 The role of ethnic differences in the pathogenesis and management of cardiovascular disorders is increasingly recognized. Subjects of South Asian (SA) origin (ie, originating from India, Pakistan, and Bangladesh) who represent the largest ethnic minority group in the United Kingdom commonly experience coronary artery disease with a higher mortality rate when compared with the white population. 3, 4 Heart failure in SAs develops at a younger age and results in 60% more hospitalizations compared with subjects of other ethnic origin. 5 In addition, there are epidemiological and pathological differences between subjects with HF from different ethnic groups, although the pathophysiological mechanisms of such differences are still poorly understood. 6, 7 Clinical Perspective on p 762
The endothelium plays a critical role in the regulation of vascular tone, recruitment of leukocytes (and other inflammatory processes), maintenance of balance between the procoagulant and anticoagulant states, and many other pathophysiological processes. 8 Impairment of endothelial function is associated with negative outcome in various cardiovascular disorders but seems particularly important in subjects with impaired cardiac contractility. Indeed, impairment of endothelial response to hyperemia or acetylcholine is a significant and independent predictor of negative outcome (including death and rehospitalization) in HF, irrespectively of its cause. 9 -14 Although research has mostly focused on subjects with clinically apparent cardiovascular morbidity, even healthy SAs have worse parameters of endothelial function compared with healthy white subjects. 15 However, the pattern of endothelial function in SAs with HF has not been specifically studied.
In this study, we hypothesized the presence of ethnic differences in endothelial macrovascular and microvascular function between subjects with HF of SA, white, and African Caribbean (AC) origin. Macrovascular function was quantified by flow-mediated dilation (FMD) of the brachial artery in response to reactive hyperemia, whereas arterial stiffness was assessed by quantification of the pulse-wave velocity (PWV). Microvascular function was quantified by forearm laser Doppler flowmetry using skin iontophoresis with acetylcholine and sodium nitroprusside. We contrasted these measures of localized endothelial function by measuring the numbers of endothelial microparticles (EMPs) that may arise from any vascular bed. 16 
Methods
Fifty subjects of SA origin were compared with 50 age-and sex-matched whites and 28 ACs with HF. All HF subjects had a left ventricular (LV) ejection fraction of Ͻ40%, confirmed by echocardiography (see later) and were clinically stable at assessment, with no hospitalization or therapy changes in the preceding 3 months. Subjects with atrial fibrillation, cancer, rheumatoid arthritis, or hemodynamically significant valvular heart disease or those taking hormone replacement therapy were excluded.
The SA subjects with HF were compared with 2 age-and sex-matched control groups of 40 SA "disease controls" (DCs; ie, subjects with significant coronary artery disease diagnosed during elective coronary angiography but with normal LV systolic function) and 40 "healthy controls" (HCs) with no vascular, metabolic, neoplastic, or inflammatory disease, revealed by careful history, examination findings, and routine laboratory test results.
The marginal matching has been performed in the study. All study subjects fasted for 12 hours and abstained from smoking, alcohol, tea, and coffee for 24 hours before the study. The subjects were advised to omit their medications on the study day and the evening before because a more prolonged treatment omission was deemed unethical. All scans were performed in a quiet, darkened, temperature-controlled room after resting for 15 to 20 minutes. Ethical approval was granted by the local research ethics committee, and written informed consent was obtained from all participants.
Echocardiography
Cardiac function was assessed by 2-dimensional echocardiography (Phillips iE33 ultrasound machine; Bothel, WA). Modern off-line QLAB software (Xcelera, Phillips Ultrasound Quantification Module) was used for quantification of parameters of cardiac structure and function. Left ventricular volumes and ejection fraction were measured using the modified Simpson biplane method. 17 For diastolic function assessment, transmitral flow was obtained in the apical 4-chamber position, where the pulsed Doppler sample volume cursor was placed in parallel with the direction of flow. Mitral early inflow velocity (E and A) was measured by a conventional Doppler measurement technique. Early diastolic lateral mitral annular velocity (E') was measured by tissue Doppler imaging, with the E/E' ratio calculated as a parameter of diastolic function. The left atrial diameter, the thickness of the posterior wall, and the interventricular septum were measured in M-mode. Interobserver and intraobserver variability values for these echocardiographic parameters in our laboratory are Ͻ5%.
FMD Data
The FMD was assessed according to the published guidelines. 18 High-resolution ultrasonographic scanning of the right brachial artery was performed with a 10-MHz probe 3 to 5 cm above the antecubital fossa, with subjects lying flat and the probe kept in the same position throughout the study. Anterior to posterior wall diameters (leading edge to leading edge) were recorded simultaneously, with synchronization by the R-wave on ECG. For every stage, the arterial diameter was calculated as an average of 5 measurements of 3 consecutive cardiac cycles. Endotheliumdependent dilation was assessed by response to flow-mediated hyperemia. The sphygmomanometer cuff placed around the right upper arm was inflated to 30 to 40 mm Hg above the systolic blood pressure for 5 minutes, followed by prompt deflation and recording of brachial artery images for 5 minutes with the maximal recorded artery diameter used for the analysis. Once the baseline brachial artery diameter and flow were restored, endothelium-independent dilation was assessed 3 minutes after sublingual administration of 0.4 mg of glycerol trinitrate (Nitrolingual, Hohenlockstedt, Germany). Endothelium-dependent and endothelium-independent responses were estimated as a percentage of the brachial diameter changes compared with baseline levels. Interobserver and intraobserver variability values for the technique in our laboratory (nϭ10) are 2.7% and 1.9%, respectively. 19
Laser Doppler Flowmetry
An assessment of microvascular endothelial function has been performed using a laser Doppler perfusion monitor (DRT system with MIC1-e iontophoresis controller; Moor Instruments, Axminster, UK) with upper forearm iontophoresis (0.1 mA for 60 seconds) of 1% acetylcholine (Sigma-Aldrich; Dorset, UK) to evaluate endothelial-dependant response and 1% sodium nitroprusside (Sigma-Aldrich) to evaluate endothelium-independent response. 20 Maximum percentage changes in perfusion were calculated using mean baseline perfusion (during 1 minute of baseline scanning) and maximum perfusion during the tests, and the analysis was performed offline using Moor software. This technique was validated in our laboratory, and intraobserver variability (blinded stored data analysis) was Ͻ1% for both acetylcholine and sodium nitroprusside. Interobserver variability (ie, variability of the results from 2 individuals, each scanned on 5 different occasions) was 11.2% for acetylcholine and 17.5% for sodium nitroprusside.
PWV and Pulse-Wave Analysis
Carotid-femoral PWV, carotid-radial PWV, and aortic augmentation index were measured using the Sphygmocor device (Sphygmocor; Atcor Medical, Sydney, Australia). Radial artery waveforms were recorded over 10 seconds using a high-fidelity hand-held applanation tonometer to perform pulse-wave analysis and calculate the aortic augmentation index using an inbuilt modern Sphygmocor CVMS software system (version 8). The carotid-femoral PWV (predominantly arteries of elastic type) and the carotid-radial PWV (predominantly arteries of muscular type) were obtained by making sequential ECG-gated tonometer recordings at the carotid, femoral, and radial arteries. The straight-line distances between the sternal notch and waveform measurement sites were determined, and path length was taken as the difference between the 2 distances. This technique was validated in our laboratory, and interobserver and intraobserver variability (nϭ10) values were 10% and 5.1%, respectively. 19
EMP Data
A venous blood sample was taken from the antecubital vein into citrated Vacutainers (Becton Dickinson; Oxford, UK). Samples were centrifuged at 2880g for 15 minutes, and plasma was stored at Ϫ70°C. Quantification of EMPs was performed using flow cytometry (FACSCalibur; Becton Dickinson). For batched analysis, 50 L of defrosted citrated plasma was incubated with fluorochrome-labeled monoclonal anti-144-PEantibodies (clone 123413; R&D Systems, Abingdon, UK) for 20 minutes in the dark at room temperature. Afterwards, 25 L of CytoCount beads (DakoCytomation; Glostrup, Denmark) and 200 L of phosphate-buffered saline were then added. Acquired events were plotted according to their forward and side scatter characteristics in log scales and gated to include events Ͻ1 m (defined using latex microbeads; Sigma-Aldrich) but to exclude electronic noise. The size of the region was kept the same for all study samples. The EMPs were defined as CD144 ϩ microparticles. The degree of positivity was defined using species-, immunoglobulin-, and protein mass-matched isotype controls from the same manufacturer (clone 20116; R&D Systems). A minimum of 100 000 microparticles was collected for analysis per sample. An absolute count of EMPs was obtained using their proportion to count beads and expressed as the number of events per microliter of plasma. Duplicate agreement and intraobserver variability values were 3.5% and 11.7%, respectively.
Statistical Analysis and Power Calculation
Data are expressed as meanϮSD for normally distributed data or median with first and third quartiles for nonnormally distributed data. Study data were analyzed by 1-way ANOVA. A post hoc Tukey test was performed to assess intergroup differences where appropriate. Log transformation of nonnormally distributed variables was performed before the ANOVA. A 2 test was used for the comparison of the categorical variables between 3 groups. When such comparisons showed significant differences, pairwise 2 tests were performed to establish any differences between individual groups. PϽ0.05 (2 tailed) was considered statistically significant. SPSS 17 (SPSS, Inc; Chicago, Ill) statistical software was used to perform the statistical analyses. Multivariable regression analysis was performed to determine factors associated with endothelial dysfunction in HF subjects. On the basis of our previous work on the study parameters (arterial stiffness and endothelial damage/dysfunction), we calculated that a sample size of 25 subjects in each group would have 80% power to detect a difference of 0.5 SDs in FMD. 19 For further confidence, we aimed to recruit 50 subjects per group for the interethnic comparisons and 40 subjects per each control group.
Results
Subjects with HF from different ethnic groups were largely well matched for demographic features (Table 1) . Most patients had an ischemic cause of HF (82% of SAs, 80% of whites, and 79% of ACs; Pϭ0.71). More subjects of AC origin had a history of hypertension compared with whites (Pϭ0.012), and the mean diastolic blood pressure was highest in ACs (Pϭ0.04). Whites had less diabetes mellitus than both SAs and ACs (PϽ0.001). In addition, ACs had a higher body mass index (Pϭ0.01) and a lower leukocyte count (Pϭ0.02). The higher prevalence of diabetes associated with increased body mass index in ACs could reflect more features of metabolic syndrome, compared with other ethnic groups. The 3 ethnic study groups were matched for most medications (Table 1) , with the exception of statins, which were more commonly taken by SAs. For the second comparison of individuals of SA origin (ie, HF versus DCs and HCs), the groups were well matched for age, sex, body mass index, and smoking ( Table 2 ). The DCs and HF subjects had lower hemoglobin and high-density lipoprotein cholesterol levels, a higher leukocyte count, and a higher creatinine level than the HCs.
FMD Data
The SAs with HF had significantly lower FMD compared with DCs and HCs (Pϭ0.033 and PϽ0.001, respectively; Table 3 ). The SAs and ACs with HF had similar values of FMD (Pϭ0.98), which were significantly lower compared with whites (PϽ0.001 and Pϭ0.01, respectively; Table 4 ; Figure 1 ). No significant difference in the baseline diameter of brachial artery and endothelium-independent response to glycerol trinitrate was observed between the compared groups (Pϭ0.53 for comparison with HCs and DCs, and Pϭ0.77 for interethnic comparisons).
Microvascular Function
The SAs with HF had a significantly lower endotheliummediated microvascular response to acetylcholine compared with DCs and HCs (PϽ0.001 for both, Table 3 ). The SAs had a significantly lower response to acetylcholine compared with whites and ACs (PϽ0.001, Table 4 , Figure 2 ). There was no significant difference in response to acetylcholine between subjects of white and AC origin (Pϭ0.88). There was no ethnic difference in baseline skin perfusion (Pϭ0.81).
Arterial Stiffness
Carotid-femoral PWV was significantly higher in SAs with HF compared with healthy individuals (Pϭ0.048, Table 3 ). No significant difference in carotid-radial PWV and augmentation index was found. No significant ethnic difference in PWV (carotid-femoral and carotid-radial) in HF subjects was evident ( Table 4 ). The aortic augmentation index was significantly lower among AC subjects compared with other ethnic groups (Pϭ0.044 compared with SAs, and Pϭ0.033 compared with whites).
EMP Data
The median EMP count was significantly different among the 3 SA groups (Kruskal-Wallis test, Pϭ0.04) but not significantly different between the individual groups (post hoc tests: Pϭ0.08 between HCs and HF subjects, and Pϭ0.07 between HCs and DCs; Table 3 ). The EMPs were significantly different between the 3 HF ethnic groups (Kruskal-Wallis test, Pϭ0.04) but were not significantly different on post hoc testing (SAs versus ACs, Pϭ0.07; and SAs versus whites, Pϭ0.10) ( Table 4 and Figure 3 ).
Multivariable Analysis
By using linear regression analysis, FMD in HF subjects (nϭ128) was significantly associated with age, New York Heart Association (NYHA) class, history of hypertension, glucose and total cholesterol levels, and carotid-femoral PWV ( Table 5 ). The microvascular endothelial function in HF significantly correlated with diabetes, glucose and highdensity lipoprotein levels, smoking, and ethnicity. The carotid-femoral PWV was significantly associated with age, diabetes, systolic and diastolic blood pressure levels, glomerular filtration rate, glucose levels, and FMD. The LV ejection fraction was the only parameter significantly correlated with carotid-radial PWV. Ethnicity and NYHA class were associated with the aortic augmentation index. Ethnicity was not correlated with the carotid-femoral PWV or the carotid-radial PWV. On univariate analysis, the EMP count was significantly associated with ethnicity, LV ejection fraction, and systolic blood pressure.
After adjustment for other significant clinical and demographic variables in a multivariable analysis, ethnicity was significantly associated with microvascular endothelial function (ie, response to acetylcholine) ( Table 6 ). Although significantly more SA patients with HF received statins compared with whites, statin use was not significantly correlated with parameters of endothelial function and arterial stiffness ( Table 7) . 
Discussion
In this study, we observed, for the first time to our knowledge, significant ethnic differences in endothelial function in a cohort of 128 subjects with systolic HF. The white ethnic group had significantly higher values of FMD of the brachial artery compared with other ethnic groups, with no difference seen between SA and AC subjects. The impact of endothelial dysfunction on the pathogenesis and outcome of systolic HF is well recognized. Numerous studies [21] [22] [23] have demonstrated peripheral endothelium- dependant vasomotor abnormalities in HF, as assessed by brachial artery FMD or forearm blood flow changes in response to acetylcholine. Direct evidence for endothelial dysfunction in the genesis of hemodynamic abnormalities in HF has been provided by the infusion of NG-monomethyl-Larginine, an inhibitor of NO production, into volunteers with HF. 24 Also, there is an independent significant association of endothelial dysfunction with a negative outcome in HF, whether in mild HF (NYHA class I), with relatively preserved myocardial contractility, or more advanced HF (NYHA class IV), with severely depressed LV function. 9, 12 The predictive value of FMD on the outcome does not seem to be affected by HF cause. Also, FMD significantly predicts the likelihood of response to cardiac resynchronization therapy, independently of QRS duration, LV ejection fraction, or LV dyssynchrony. 11 We found that SAs with HF had significant impairment of macrovascular endothelial function compared with both con-trol groups, a finding that accords with well-recognized macrovascular endothelial abnormalities in other ethnic groups. 13 However, our nonwhite ethnic groups had differences in the proportion of patients with diabetes, a potent contributor to endothelial dysfunction. 25 When the study results were adjusted for important clinical and demographic covariables, such as age, NYHA class, and diabetic status, ethnicity was no longer associated with FMD in patients with HF. This analysis indicates that ethnicity-related differences in comorbidities accompanying HF, rather than ethnicity itself, may determine the status of macrovascular endothelial dysfunction.
In contrast to robust evidence of macrovascular endothelial dysfunction in HF, only limited data are available on the status of microvascular endothelial function in such subjects. 26, 27 In this study, we show significant impairment of cutaneous response to acetylcholine in SAs with HF. Indeed, we show, for the first time to our knowledge, that SAs with HF had significant impairment of microvascular endothelial function compared with other ethnic groups, and ethnicity was still associated with microvascular endothelial dysfunction, even after adjustment for age, presence of hypertension and diabetes, blood pressure, and glucose levels. We could hypothesize that these abnormalities of endotheliumdependant regulation of microvascular flow could account for the unexplained discrepancy between the distinctly more prominent HF symptoms in SA subjects (eg, a much higher hospitalization rate) despite relatively preserved LV contractility compared with white HF subjects. 5, 28 Most, but not all, studies have shown the ability of statins to improve FMD in subjects with systolic HF. 29 -32 The study with the longest controlled period of treatment with statins in HF (12 weeks) failed to significantly improve FMD. 32 These observations suggest that beneficial effects of statins on vasomotor endothelial function in HF may wear off during longer-term treatment. Also, to our knowledge, there are no published data on the effects of statins on microvascular endothelial function in patients with HF. In our study, treatment with statins was not associated with parameters of macrovascular (ie, FMD) and microvascular (ie, response to acetylcholine) endothelial function. Thus, despite more SA subjects with HF receiving statins compared with white subjects, this is unlikely to significantly affect the ethnic differences seen in the study, particularly given that whites had a higher FMD than SAs.
In contrast to measures of endothelial function, parameters of arterial stiffness did not differ between SA subjects with HF and matched DCs. No significant ethnic difference in PWV was observed, but the aortic augmentation index was slightly lower in ACs. Ethnicity was associated with the aortic augmentation index (but not with PWV). However, its significance failed to be independent of other factors affecting aortic stiffness.
The EMPs have emerged as a novel marker of endothelial dysfunction related to the pathogenesis of various cardiovascular disorders. 16 Recently, EMPs have been of significant predictive value for negative clinical outcomes in subjects with HF. 33 However, we were unable to identify any data on EMP count in subjects with systolic HF compared with individuals with normal cardiac contractility. In this study, we observed a trend toward increased values of EMPs in subjects with HF compared with control groups and increased EMPs in SAs with HF compared with other ethnic groups.
Although ethnicity was significantly associated with EMP count in HF on linear regression, this was not significant after adjustment (Pϭ0.06). It is, therefore, unclear whether ethnicity affects EMPs as a marker of endothelial dysfunction, but given the strong trend toward higher EMPs in SAs with HF observed in this study, further investigations are probably warranted.
Previously, subjects of SA origin have presented with symptoms of congestive HF on average 8 years earlier than whites. 5 In addition, SAs with HF have Ϸ60% more hospital admissions in general and a 5-fold higher risk of presenting with HF at the hospital among elderly individuals without any obvious objective signs of more severe LV impairment. 5, 34 A higher prevalence of diastolic dysfunction in SAs has been suggested but is not well documented. 35 Accordingly, it is unclear which factors could be responsible for more HF symptoms in SAs.
It is increasingly recognized that endothelial dysfunction could be a significant contributor to the development of HF with preserved ejection fraction, and it may also affect the symptoms of systolic HF. 36 Previously, even healthy SAs had worse parameters of endothelial function compared with healthy whites. 15 The present study shows that SA ethnicity is associated with more severe endothelial dysfunction, even after adjustment for the cardiovascular risk factors, including diabetes. It is, thus, tempting to speculate that more prominent endothelial dysfunction may be at least partly responsible for the more symptomatic status in SAs with HF. However, further research would be needed to prove the concept.
Despite the higher age-adjusted prevalence, greater hospitalization rate, and worse risk factor profile, SA subjects with HF appear to have a better prognosis than whites. The 30-day, 1-year, and 2-year survival rates are consistently better among SAs. 5, 28 Multivariable analysis has also confirmed an independent association of SA ethnicity with more favorable prognosis in HF. 5, 28 Again, it is plausible that better prognosis in SAs may reflect the situation that earlier presentation with HF due to symptoms associated with endothelial dysfunction leads to earlier and timely initiation of the treatment. In addition, the study results identify microvascular endothelial dysfunction as a potential target for the therapeutic interventions in SAs with HF.
One limitation of the study is the relatively few AC subjects. There were difficulties in AC subjects who met inclusion criteria, and many of them were reluctant to participate in this research. Also, this study did not aim to assess clinical and prognostic implications of the ethnic differences found in endothelial function. In addition, our HCs were defined from careful clinical history and examination findings, but because angiography was not performed in these healthy subjects (for ethical reasons), there is a possibility that some of them could have subclinical coronary artery disease.
In conclusion, there are significant ethnicity-related differences in both microvascular and macrovascular endothelial function in systolic HF. Ethnicity is associated with microvascular endothelial dysfunction in this disorder.
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CLINICAL PERSPECTIVE
It is increasingly recognized that endothelial dysfunction could be a significant contributor to the development of HF with preserved ejection fraction, and it may also affect the symptoms and progression of systolic HF. It was previously demonstrated that even healthy South Asians (SAs) have worse parameters of endothelial function compared with healthy whites. To further examine ethnic differences in endothelial function in HF, we recruited SA, white, and African Caribbean subjects with systolic HF, and disease and healthy controls, and assessed macrovascular endothelial function, arterial stiffness, and microvascular endothelial function. Significant ethnic differences in endothelial function were evident in subjects with HF, with ethnicity being associated with microvascular endothelial dysfunction. The results of the present study also show that SA ethnicity is associated with more severe endothelial dysfunction, even after adjustment for the cardiovascular risk factors, including diabetes. The study results identify microvascular endothelial dysfunction as a potential target for the therapeutic interventions in SAs with HF.
